|
SLC35E1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.714200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.144200E-01 |
| Normal-vs-Stage2 |
3.833800E-01 |
| Normal-vs-Stage3 |
2.050000E-01 |
| Normal-vs-Stage4 |
6.538600E-01 |
| Stage1-vs-Stage2 |
9.642200E-01 |
| Stage1-vs-Stage3 |
6.591000E-01 |
| Stage1-vs-Stage4 |
6.521200E-01 |
| Stage2-vs-Stage3 |
7.950400E-01 |
| Stage2-vs-Stage4 |
6.940000E-01 |
| Stage3-vs-Stage4 |
4.712200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.908000E-01 |
| Normal-vs-AfricanAmerican |
8.394800E-01 |
| Normal-vs-Asian |
3.530200E-01 |
| Caucasian-vs-AfricanAmerican |
5.804800E-01 |
| Caucasian-vs-Asian |
9.644800E-01 |
| AfricanAmerican-vs-Asian |
5.712000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.865810E-01 |
| Normal-vs-Female |
3.389400E-01 |
| Male-vs-Female |
5.113200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
4.884000E-01 |
| Normal-vs-Age(41-60Yrs) |
1.270420E-01 |
| Normal-vs-Age(61-80Yrs) |
3.100600E-01 |
| Normal-vs-Age(81-100Yrs) |
9.309600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.947400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.742600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.005000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.435600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.443400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.811800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.166200E-01 |
| Classical-VS-Follicular |
8.419900E-04 |
| Classical-VS-Other |
4.888200E-02 |
| Classical-VS-Normal |
9.036400E-01 |
| Tall-VS-Follicular |
3.037800E-01 |
| Tall-VS-Other |
1.626400E-01 |
| Tall-VS-Normal |
3.205800E-01 |
| Follicular-VS-Other |
4.611800E-01 |
| Follicular-VS-Normal |
1.798480E-02 |
| Other-VS-Normal |
3.784300E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.447380E-01 |
| Normal-vs-N1 |
5.878100E-02 |
| N0-vs-N1 |
3.526400E-01 |
|
|
